ArticleScientific reports2023

Advanced glycation end product (AGE) targeting antibody SIWA318H is efficacious in preclinical models for pancreatic cancer.

Gabriela R Rossi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.